Back
Protagonist Therapeutics Stock Price Chart
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
42
PTGX
Protagonist Therapeutics
Last Price:
$39.25
Seasonality Move:
28.98%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight selling pressure.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.4 | Sell |
| 20-day SMA: | 41.45 | Sell |
| 50-day SMA: | 43.78 | Sell |
| 200-day SMA: | 37.11 | Buy |
| 8-day EMA: | 40.36 | Sell |
| 20-day EMA: | 41.25 | Sell |
| 50-day EMA: | 42.48 | Sell |
| 200-day EMA: | 37.76 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.99 | Sell |
| Relative Strength Index (14 RSI): | 41.13 | Sell |
| Chaikin Money Flow: | -119798 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.68 - 43.68) | Sell |
| Bollinger Bands (100): | (40.3 - 46.26) | Sell |
Protagonist Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 39.30 while PTGX 8-day simple moving average is 40.40, which is a Sell signal.
-
The stock price of PTGX is 39.30 while Protagonist Therapeutics 20-day SMA is 41.45, which makes it a Sell.
-
Protagonist Therapeutics 50-day simple moving average is 43.78 while PTGX share price is 39.30, making it a Sell technically.
-
PTGX stock price is 39.30 and Protagonist Therapeutics 200-day simple moving average is 37.11, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
42
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a SellThe current Protagonist Therapeutics [PTGX] share price is $39.30. The Score for PTGX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
2.3B
Price in USD:
39.30
Share Volume:
249.3K
Protagonist Therapeutics 52-Week Range
52-Week High:
48.89
52-Week Low:
21.43
Sell
42
Protagonist Therapeutics (PTGX)
is a Sell
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?The Protagonist Therapeutics stock price is 39.30 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is overvalued.
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 39.30 while PTGX 8-day exponential moving average is 40.36, which is a Sell signal.
-
The stock price of PTGX is 39.30 while Protagonist Therapeutics 20-day EMA is 41.25, which makes it a Sell.
-
Protagonist Therapeutics 50-day exponential moving average is 42.48 while PTGX share price is 39.30, making it a Sell technically.
-
PTGX stock price is 39.30 and Protagonist Therapeutics 200-day simple moving average is 37.76, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.57 per share, and a decrease next year of $3.76 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is -0.99, suggesting Protagonist Therapeutics is a Sell
-
Protagonist Therapeutics Relative Strength Index (RSI) is 41.13, which suggest Protagonist Therapeutics is oversold
-
The Bollinger Bands (25) for Protagonist Therapeutics is (39.68 - 43.68), which suggest Protagonist Therapeutics is a Sell
-
The Bollinger Bands (100) for Protagonist Therapeutics is (40.3 - 46.26), which suggest Protagonist Therapeutics is a Sell
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.